Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | X026404 | — |
No additional AE; HCP calling to report administration of MMR-II with TE on 08/12/2025; This spontaneous report was received from a other health professional and refers to a 60-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 12-AUG-2025, the patient was vaccinated with an improperly storage of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) for prophylaxis (dose, route of administration, anatomical location were not reported, lot number X026404, which was verified to be valid, expiration date not reported, but upon internal review established on 08-NOV-2025), the vaccine was reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT), (lot number and expiration date were not reported). The administered dose of the vaccine experienced a temperature excursion 15.1 degrees Fahrenheit for 15 minutes, and previous excursion was 13.5 degrees Fahrenheit, for 1 hour and 30 minutes, it was not reported if the information was recorded by a data logger or not. There was no adverse effect reported.
STERILE DILUENT